Global and China Seasonal Influenza Vaccine Market Insights, Forecast to 2026

Publisher Name :
Date: 16-Oct-2020
No. of pages: 140
Inquire Before Buying

Seasonal Influenza Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Seasonal Influenza Vaccine market is segmented into

- Trivalent Influenza Vaccine

- Quadrivalent Influenza Vaccine

- Other

Segment by Application, the Seasonal Influenza Vaccine market is segmented into

- Children

- Adults

- Elderly

- Pregnancy

Regional and Country-level Analysis

The Seasonal Influenza Vaccine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Seasonal Influenza Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Seasonal Influenza Vaccine Market Share Analysis

Seasonal Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Seasonal Influenza Vaccine business, the date to enter into the Seasonal Influenza Vaccine market, Seasonal Influenza Vaccine product introduction, recent developments, etc.

The major vendors covered:

- GSK

- Sinovac

- Changsheng

- CCBIO

- Aleph Biomedical

- Sanofi

- Lanzhou Institute Of Biological Product

- Siobp

- Hualan Bio

- Tianyuan Bio-Pharma

- Vaxtec

- Hissen

- Abbott

- Novartis

- Tasly&Jenner

- Tiantan

Global and China Seasonal Influenza Vaccine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Seasonal Influenza Vaccine Product Introduction
1.2 Market Segments
1.3 Key Seasonal Influenza Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Seasonal Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Trivalent Influenza Vaccine
1.4.3 Quadrivalent Influenza Vaccine
1.4.4 Other
1.5 Market by Application
1.5.1 Global Seasonal Influenza Vaccine Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Adults
1.5.4 Elderly
1.5.5 Pregnancy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Seasonal Influenza Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Seasonal Influenza Vaccine Revenue 2015-2026
2.1.2 Global Seasonal Influenza Vaccine Sales 2015-2026
2.2 Global Seasonal Influenza Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Seasonal Influenza Vaccine Historical Market Size by Region (2015-2020)
2.3.1 Global Seasonal Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Seasonal Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Seasonal Influenza Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Seasonal Influenza Vaccine Sales Forecast by Region (2021-2026)
2.4.2 Global Seasonal Influenza Vaccine Revenue Forecast by Region (2021-2026)
3 Global Seasonal Influenza Vaccine Competitor Landscape by Players
3.1 Global Top Seasonal Influenza Vaccine Sales by Manufacturers
3.1.1 Global Seasonal Influenza Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Seasonal Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Seasonal Influenza Vaccine Manufacturers by Revenue
3.2.1 Global Seasonal Influenza Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Seasonal Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Seasonal Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccine Revenue in 2019
3.2.5 Global Seasonal Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Seasonal Influenza Vaccine Price by Manufacturers
3.4 Global Seasonal Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Seasonal Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Seasonal Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Seasonal Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Seasonal Influenza Vaccine Market Size by Type (2015-2020)
4.1.1 Global Seasonal Influenza Vaccine Sales by Type (2015-2020)
4.1.2 Global Seasonal Influenza Vaccine Revenue by Type (2015-2020)
4.1.3 Seasonal Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Seasonal Influenza Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Seasonal Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Seasonal Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Seasonal Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Seasonal Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Seasonal Influenza Vaccine Market Size by Application (2015-2020)
5.1.1 Global Seasonal Influenza Vaccine Sales by Application (2015-2020)
5.1.2 Global Seasonal Influenza Vaccine Revenue by Application (2015-2020)
5.1.3 Seasonal Influenza Vaccine Price by Application (2015-2020)
5.2 Seasonal Influenza Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Seasonal Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Seasonal Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Seasonal Influenza Vaccine Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Seasonal Influenza Vaccine Market Size YoY Growth 2015-2026
6.1.1 China Seasonal Influenza Vaccine Sales YoY Growth 2015-2026
6.1.2 China Seasonal Influenza Vaccine Revenue YoY Growth 2015-2026
6.1.3 China Seasonal Influenza Vaccine Market Share in Global Market 2015-2026
6.2 China Seasonal Influenza Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Seasonal Influenza Vaccine Players by Sales (2015-2020)
6.2.2 China Top Seasonal Influenza Vaccine Players by Revenue (2015-2020)
6.3 China Seasonal Influenza Vaccine Historic Market Review by Type (2015-2020)
6.3.1 China Seasonal Influenza Vaccine Sales Market Share by Type (2015-2020)
6.3.2 China Seasonal Influenza Vaccine Revenue Market Share by Type (2015-2020)
6.3.3 China Seasonal Influenza Vaccine Price by Type (2015-2020)
6.4 China Seasonal Influenza Vaccine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Seasonal Influenza Vaccine Sales Forecast by Type (2021-2026)
6.4.2 China Seasonal Influenza Vaccine Revenue Forecast by Type (2021-2026)
6.4.3 China Seasonal Influenza Vaccine Price Forecast by Type (2021-2026)
6.5 China Seasonal Influenza Vaccine Historic Market Review by Application (2015-2020)
6.5.1 China Seasonal Influenza Vaccine Sales Market Share by Application (2015-2020)
6.5.2 China Seasonal Influenza Vaccine Revenue Market Share by Application (2015-2020)
6.5.3 China Seasonal Influenza Vaccine Price by Application (2015-2020)
6.6 China Seasonal Influenza Vaccine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Seasonal Influenza Vaccine Sales Forecast by Application (2021-2026)
6.6.2 China Seasonal Influenza Vaccine Revenue Forecast by Application (2021-2026)
6.6.3 China Seasonal Influenza Vaccine Price Forecast by Application (2021-2026)
7 North America
7.1 North America Seasonal Influenza Vaccine Market Size YoY Growth 2015-2026
7.2 North America Seasonal Influenza Vaccine Market Facts & Figures by Country
7.2.1 North America Seasonal Influenza Vaccine Sales by Country (2015-2020)
7.2.2 North America Seasonal Influenza Vaccine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Seasonal Influenza Vaccine Market Size YoY Growth 2015-2026
8.2 Europe Seasonal Influenza Vaccine Market Facts & Figures by Country
8.2.1 Europe Seasonal Influenza Vaccine Sales by Country
8.2.2 Europe Seasonal Influenza Vaccine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Seasonal Influenza Vaccine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Seasonal Influenza Vaccine Market Facts & Figures by Country
9.2.1 Asia Pacific Seasonal Influenza Vaccine Sales by Region (2015-2020)
9.2.2 Asia Pacific Seasonal Influenza Vaccine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Seasonal Influenza Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Seasonal Influenza Vaccine Market Facts & Figures by Country
10.2.1 Latin America Seasonal Influenza Vaccine Sales by Country
10.2.2 Latin America Seasonal Influenza Vaccine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Seasonal Influenza Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Seasonal Influenza Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Seasonal Influenza Vaccine Sales by Country
11.2.2 Middle East and Africa Seasonal Influenza Vaccine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Seasonal Influenza Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Sinovac
12.2.1 Sinovac Corporation Information
12.2.2 Sinovac Description and Business Overview
12.2.3 Sinovac Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sinovac Seasonal Influenza Vaccine Products Offered
12.2.5 Sinovac Recent Development
12.3 Changsheng
12.3.1 Changsheng Corporation Information
12.3.2 Changsheng Description and Business Overview
12.3.3 Changsheng Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Changsheng Seasonal Influenza Vaccine Products Offered
12.3.5 Changsheng Recent Development
12.4 CCBIO
12.4.1 CCBIO Corporation Information
12.4.2 CCBIO Description and Business Overview
12.4.3 CCBIO Sales, Revenue and Gross Margin (2015-2020)
12.4.4 CCBIO Seasonal Influenza Vaccine Products Offered
12.4.5 CCBIO Recent Development
12.5 Aleph Biomedical
12.5.1 Aleph Biomedical Corporation Information
12.5.2 Aleph Biomedical Description and Business Overview
12.5.3 Aleph Biomedical Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Aleph Biomedical Seasonal Influenza Vaccine Products Offered
12.5.5 Aleph Biomedical Recent Development
12.6 Sanofi
12.6.1 Sanofi Corporation Information
12.6.2 Sanofi Description and Business Overview
12.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanofi Seasonal Influenza Vaccine Products Offered
12.6.5 Sanofi Recent Development
12.7 Lanzhou Institute Of Biological Product
12.7.1 Lanzhou Institute Of Biological Product Corporation Information
12.7.2 Lanzhou Institute Of Biological Product Description and Business Overview
12.7.3 Lanzhou Institute Of Biological Product Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Products Offered
12.7.5 Lanzhou Institute Of Biological Product Recent Development
12.8 Siobp
12.8.1 Siobp Corporation Information
12.8.2 Siobp Description and Business Overview
12.8.3 Siobp Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Siobp Seasonal Influenza Vaccine Products Offered
12.8.5 Siobp Recent Development
12.9 Hualan Bio
12.9.1 Hualan Bio Corporation Information
12.9.2 Hualan Bio Description and Business Overview
12.9.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Hualan Bio Seasonal Influenza Vaccine Products Offered
12.9.5 Hualan Bio Recent Development
12.10 Tianyuan Bio-Pharma
12.10.1 Tianyuan Bio-Pharma Corporation Information
12.10.2 Tianyuan Bio-Pharma Description and Business Overview
12.10.3 Tianyuan Bio-Pharma Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Products Offered
12.10.5 Tianyuan Bio-Pharma Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GSK Seasonal Influenza Vaccine Products Offered
12.11.5 GSK Recent Development
12.12 Hissen
12.12.1 Hissen Corporation Information
12.12.2 Hissen Description and Business Overview
12.12.3 Hissen Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Hissen Products Offered
12.12.5 Hissen Recent Development
12.13 Abbott
12.13.1 Abbott Corporation Information
12.13.2 Abbott Description and Business Overview
12.13.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Abbott Products Offered
12.13.5 Abbott Recent Development
12.14 Novartis
12.14.1 Novartis Corporation Information
12.14.2 Novartis Description and Business Overview
12.14.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Novartis Products Offered
12.14.5 Novartis Recent Development
12.15 Tasly&Jenner
12.15.1 Tasly&Jenner Corporation Information
12.15.2 Tasly&Jenner Description and Business Overview
12.15.3 Tasly&Jenner Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Tasly&Jenner Products Offered
12.15.5 Tasly&Jenner Recent Development
12.16 Tiantan
12.16.1 Tiantan Corporation Information
12.16.2 Tiantan Description and Business Overview
12.16.3 Tiantan Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Tiantan Products Offered
12.16.5 Tiantan Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Seasonal Influenza Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Seasonal Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Seasonal Influenza Vaccine Market Segments
Table 2. Ranking of Global Top Seasonal Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Seasonal Influenza Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Trivalent Influenza Vaccine
Table 5. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 6. Major Manufacturers of Other
Table 7. Global Seasonal Influenza Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 8. Global Seasonal Influenza Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 9. Global Seasonal Influenza Vaccine Sales by Regions 2015-2020 (K Doses)
Table 10. Global Seasonal Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 11. Global Seasonal Influenza Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Seasonal Influenza Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 13. Global Seasonal Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 14. Global Seasonal Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 15. Global Seasonal Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Seasonal Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccine as of 2019)
Table 17. Seasonal Influenza Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Seasonal Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Seasonal Influenza Vaccine Price (2015-2020) (USD/Dose)
Table 20. Seasonal Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Seasonal Influenza Vaccine Product Type
Table 22. Date of International Manufacturers Enter into Seasonal Influenza Vaccine Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Seasonal Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 25. Global Seasonal Influenza Vaccine Sales Share by Type (2015-2020)
Table 26. Global Seasonal Influenza Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Seasonal Influenza Vaccine Revenue Share by Type (2015-2020)
Table 28. Seasonal Influenza Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 29. Global Seasonal Influenza Vaccine Sales Share by Type (2021-2026)
Table 30. Global Seasonal Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 31. Global Seasonal Influenza Vaccine Sales Share by Application (2015-2020)
Table 32. Global Seasonal Influenza Vaccine Sales Share by Application (2021-2026)
Table 33. Global Seasonal Influenza Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Seasonal Influenza Vaccine Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Seasonal Influenza Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 36. China Seasonal Influenza Vaccine Sales (K Doses) of Key Companies (2015-2020)
Table 37. China Seasonal Influenza Vaccine Sales Share by Company (2015-2020)
Table 38. China Seasonal Influenza Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 39. China Seasonal Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 40. China Seasonal Influenza Vaccine Sales Share by Type (2015-2020)
Table 41. China Seasonal Influenza Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. China Seasonal Influenza Vaccine Price (K Doses) by Type (2015-2020)
Table 43. China Seasonal Influenza Vaccine Sales (K Doses) by Type (2021-2026)
Table 44. China Seasonal Influenza Vaccine Sales Share by Type (2021-2026)
Table 45. China Seasonal Influenza Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. China Seasonal Influenza Vaccine Revenue Share by Type (2021-2026)
Table 47. China Seasonal Influenza Vaccine Price (K Doses) by Type (2021-2026)
Table 48. China Seasonal Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 49. China Seasonal Influenza Vaccine Sales Share by Application (2015-2020)
Table 50. China Seasonal Influenza Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. China Seasonal Influenza Vaccine Sales (K Doses) by Application (2021-2026)
Table 52. China Seasonal Influenza Vaccine Sales Share by Application (2021-2026)
Table 53. China Seasonal Influenza Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. China Seasonal Influenza Vaccine Revenue Share by Application (2021-2026)
Table 55. North America Seasonal Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 56. North America Seasonal Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 57. North America Seasonal Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Seasonal Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 59. Europe Seasonal Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 60. Europe Seasonal Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 61. Europe Seasonal Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Seasonal Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Seasonal Influenza Vaccine Sales by Region (2015-2020) (K Doses)
Table 64. Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Seasonal Influenza Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Seasonal Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 67. Latin America Seasonal Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 68. Latin America Seasonal Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Seasonal Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Seasonal Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Seasonal Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 72. Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Seasonal Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Seasonal Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. GSK Seasonal Influenza Vaccine Product
Table 79. GSK Recent Development
Table 80. Sinovac Corporation Information
Table 81. Sinovac Description and Business Overview
Table 82. Sinovac Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Sinovac Product
Table 84. Sinovac Recent Development
Table 85. Changsheng Corporation Information
Table 86. Changsheng Description and Business Overview
Table 87. Changsheng Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Changsheng Product
Table 89. Changsheng Recent Development
Table 90. CCBIO Corporation Information
Table 91. CCBIO Description and Business Overview
Table 92. CCBIO Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. CCBIO Product
Table 94. CCBIO Recent Development
Table 95. Aleph Biomedical Corporation Information
Table 96. Aleph Biomedical Description and Business Overview
Table 97. Aleph Biomedical Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Aleph Biomedical Product
Table 99. Aleph Biomedical Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Sanofi Product
Table 104. Sanofi Recent Development
Table 105. Lanzhou Institute Of Biological Product Corporation Information
Table 106. Lanzhou Institute Of Biological Product Description and Business Overview
Table 107. Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Lanzhou Institute Of Biological Product Product
Table 109. Lanzhou Institute Of Biological Product Recent Development
Table 110. Siobp Corporation Information
Table 111. Siobp Description and Business Overview
Table 112. Siobp Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Siobp Product
Table 114. Siobp Recent Development
Table 115. Hualan Bio Corporation Information
Table 116. Hualan Bio Description and Business Overview
Table 117. Hualan Bio Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. Hualan Bio Product
Table 119. Hualan Bio Recent Development
Table 120. Tianyuan Bio-Pharma Corporation Information
Table 121. Tianyuan Bio-Pharma Description and Business Overview
Table 122. Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Tianyuan Bio-Pharma Product
Table 124. Tianyuan Bio-Pharma Recent Development
Table 125. Vaxtec Corporation Information
Table 126. Vaxtec Description and Business Overview
Table 127. Vaxtec Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Vaxtec Product
Table 129. Vaxtec Recent Development
Table 130. Hissen Corporation Information
Table 131. Hissen Description and Business Overview
Table 132. Hissen Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Hissen Product
Table 134. Hissen Recent Development
Table 135. Abbott Corporation Information
Table 136. Abbott Description and Business Overview
Table 137. Abbott Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Abbott Product
Table 139. Abbott Recent Development
Table 140. Novartis Corporation Information
Table 141. Novartis Description and Business Overview
Table 142. Novartis Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. Novartis Product
Table 144. Novartis Recent Development
Table 145. Tasly&Jenner Corporation Information
Table 146. Tasly&Jenner Description and Business Overview
Table 147. Tasly&Jenner Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. Tasly&Jenner Product
Table 149. Tasly&Jenner Recent Development
Table 150. Tiantan Corporation Information
Table 151. Tiantan Description and Business Overview
Table 152. Tiantan Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 153. Tiantan Product
Table 154. Tiantan Recent Development
Table 155. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 156. Key Challenges
Table 157. Market Risks
Table 158. Main Points Interviewed from Key Seasonal Influenza Vaccine Players
Table 159. Seasonal Influenza Vaccine Customers List
Table 160. Seasonal Influenza Vaccine Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Seasonal Influenza Vaccine Product Picture
Figure 2. Global Seasonal Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Other Product Picture
Figure 6. Global Seasonal Influenza Vaccine Sales Market Share by Application in 2020 & 2026
Figure 7. Children
Figure 8. Adults
Figure 9. Elderly
Figure 10. Pregnancy
Figure 11. Seasonal Influenza Vaccine Report Years Considered
Figure 12. Global Seasonal Influenza Vaccine Market Size 2015-2026 (US$ Million)
Figure 13. Global Seasonal Influenza Vaccine Sales 2015-2026 (K Doses)
Figure 14. Global Seasonal Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Seasonal Influenza Vaccine Sales Market Share by Region (2015-2020)
Figure 16. Global Seasonal Influenza Vaccine Sales Market Share by Region in 2019
Figure 17. Global Seasonal Influenza Vaccine Revenue Market Share by Region (2015-2020)
Figure 18. Global Seasonal Influenza Vaccine Revenue Market Share by Region in 2019
Figure 19. Global Seasonal Influenza Vaccine Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Seasonal Influenza Vaccine Revenue in 2019
Figure 21. Seasonal Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Seasonal Influenza Vaccine Sales Market Share by Type (2015-2020)
Figure 23. Global Seasonal Influenza Vaccine Sales Market Share by Type in 2019
Figure 24. Global Seasonal Influenza Vaccine Revenue Market Share by Type (2015-2020)
Figure 25. Global Seasonal Influenza Vaccine Revenue Market Share by Type in 2019
Figure 26. Global Seasonal Influenza Vaccine Market Share by Price Range (2015-2020)
Figure 27. Global Seasonal Influenza Vaccine Sales Market Share by Application (2015-2020)
Figure 28. Global Seasonal Influenza Vaccine Sales Market Share by Application in 2019
Figure 29. Global Seasonal Influenza Vaccine Revenue Market Share by Application (2015-2020)
Figure 30. Global Seasonal Influenza Vaccine Revenue Market Share by Application in 2019
Figure 31. China Seasonal Influenza Vaccine Sales Growth Rate 2015-2026 (K Doses)
Figure 32. China Seasonal Influenza Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. China Seasonal Influenza Vaccine Market Share in Global Market 2015-2026
Figure 34. China 5 and 10 Largest Seasonal Influenza Vaccine Players Market Share by Revenue in Seasonal Influenza Vaccine in 2019
Figure 35. China Seasonal Influenza Vaccine Revenue Share by Type (2015-2020)
Figure 36. China Seasonal Influenza Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 37. China Seasonal Influenza Vaccine Revenue Share by Application (2015-2020)
Figure 38. China Seasonal Influenza Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Seasonal Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 40. North America Seasonal Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Seasonal Influenza Vaccine Sales Market Share by Country in 2019
Figure 42. North America Seasonal Influenza Vaccine Revenue Market Share by Country in 2019
Figure 43. U.S. Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 44. U.S. Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 46. Canada Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Seasonal Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 48. Europe Seasonal Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Seasonal Influenza Vaccine Sales Market Share by Country in 2019
Figure 50. Europe Seasonal Influenza Vaccine Revenue Market Share by Country in 2019
Figure 51. Germany Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Germany Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 54. France Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 56. U.K. Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 58. Italy Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 60. Russia Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Seasonal Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 62. Asia Pacific Seasonal Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Region in 2019
Figure 64. Asia Pacific Seasonal Influenza Vaccine Revenue Market Share by Region in 2019
Figure 65. China Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 66. China Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 68. Japan Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 70. South Korea Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 72. India Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Australia Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Taiwan Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 78. Indonesia Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 80. Thailand Seasonal Influenza Vaccine Revenue Growth Rate (2015
  • Global Pets Parasiticide Medicines Market Growth (Status and Outlook) 2020-2025
    Published: 23-Oct-2020        Price: US 3660 Onwards        Pages: 117
    According to this study, over the next five years the Pets Parasiticide Medicines market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Pets Parasiticide Medicines business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Pets Parasiticide Medicines m......
  • Global Vermox Market Growth (Status and Outlook) 2020-2025
    Published: 23-Oct-2020        Price: US 3660 Onwards        Pages: 119
    According to this study, over the next five years the Vermox market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Vermox business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Vermox market by product type, application, key manufacturers and key r......
  • Global Stress Medication Market Growth (Status and Outlook) 2020-2025
    Published: 23-Oct-2020        Price: US 3660 Onwards        Pages: 133
    According to this study, over the next five years the Stress Medication market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Stress Medication business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Stress Medication market by product type, applica......
  • Global Stress Management Drug Market Growth (Status and Outlook) 2020-2025
    Published: 23-Oct-2020        Price: US 3660 Onwards        Pages: 130
    According to this study, over the next five years the Stress Management Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Stress Management Drug business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Stress Management Drug market by produc......
  • Global Kidney Cancer Medicine Market Growth (Status and Outlook) 2020-2025
    Published: 23-Oct-2020        Price: US 3660 Onwards        Pages: 130
    According to this study, over the next five years the Kidney Cancer Medicine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Kidney Cancer Medicine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Kidney Cancer Medicine market by produc......
  • Global Renal Cell Cancer Treatment Market Growth (Status and Outlook) 2020-2025
    Published: 23-Oct-2020        Price: US 3660 Onwards        Pages: 139
    According to this study, over the next five years the Renal Cell Cancer Treatment market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Renal Cell Cancer Treatment business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Renal Cell Cancer Treatment m......
  • Global Kidney Cancer Therapy Market Growth (Status and Outlook) 2020-2025
    Published: 23-Oct-2020        Price: US 3660 Onwards        Pages: 139
    According to this study, over the next five years the Kidney Cancer Therapy market will register a XX%% CAGR in terms of revenue, the global market size will reach $ XX million by 2025, from $ XX million in 2019. In particular, this report presents the global revenue market share of key companies in Kidney Cancer Therapy business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Kidney Cancer Therapy market by product t......
  • Global and China Tetanus Toxoid Vaccine Market Insights, Forecast to 2026
    Published: 22-Oct-2020        Price: US 3900 Onwards        Pages: 149
    Tetanus Toxoid Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tetanus Toxoid Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Tetanus Toxoid Vaccine mark......
  • Global and Japan Zinc Lactate Market Insights, Forecast to 2026
    Published: 22-Oct-2020        Price: US 3900 Onwards        Pages: 134
    Zinc Lactate market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Zinc Lactate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Zinc Lactate market is segmented into - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs